(Q54937005)

English

OVCAR-3

cell line

Ovcar-3
OVCAR 3
OVCAR.3
NIH:OVCAR-3
NIH:OVCAR3
NIH-OVCAR-3
NIHOVCAR3
OVCAR3

In more languages

default for all languages

No label defined

No description defined

Statements

1 reference

Cellosaurus release 49

14 July 2024

cancer cell line

1 reference

Cellosaurus release 49

14 July 2024

described by source

The relationships between glutathione, glutathione-S-transferase and cytotoxicity of platinum drugs and melphalan in eight human ovarian carcinoma cell lines

1 reference

Cellosaurus release 49

14 July 2024

Feasibility of a high-flux anticancer drug screen using a diverse panel of cultured human tumor cell lines

1 reference

Cellosaurus release 49

14 July 2024

Metallothionein gene expression and resistance to cisplatin in human ovarian cancer

1 reference

Cellosaurus release 49

14 July 2024

Biological properties of ten human ovarian carcinoma cell lines: calibration in vitro against four platinum complexes

1 reference

Cellosaurus release 49

14 July 2024

Characterization of immunotoxins active against ovarian cancer cell lines

1 reference

Cellosaurus release 49

14 July 2024

Characterization of a human ovarian carcinoma cell line (NIH:OVCAR-3) with androgen and estrogen receptors.

1 reference

Cellosaurus release 49

14 July 2024

Increased platinum-DNA damage tolerance is associated with cisplatin resistance and cross-resistance to various chemotherapeutic agents in unrelated human ovarian cancer cell lines

1 reference

Cellosaurus release 49

14 July 2024

Mutation of the PTEN tumor suppressor gene is not a feature of ovarian cancers

1 reference

Cellosaurus release 49

14 July 2024

Systematic variation in gene expression patterns in human cancer cell lines

1 reference

Cellosaurus release 49

14 July 2024

Comprehensive galectin fingerprinting in a panel of 61 human tumor cell lines by RT-PCR and its implications for diagnostic and therapeutic procedures

1 reference

Cellosaurus release 49

14 July 2024

Multicolor spectral karyotyping of serous ovarian adenocarcinoma

1 reference

Cellosaurus release 49

14 July 2024

Differentially regulated genes as putative targets of amplifications at 20q in ovarian cancers

1 reference

Cellosaurus release 49

14 July 2024

Gene expression patterns in ovarian carcinomas

1 reference

Cellosaurus release 49

14 July 2024

Regional activation of chromosomal arm 7q with and without gene amplification in taxane-selected human ovarian cancer cell lines

1 reference

Cellosaurus release 49

14 July 2024

Mutation analysis of 24 known cancer genes in the NCI-60 cell line set.

1 reference

Cellosaurus release 49

14 July 2024

Analysis of p53 mutation status in human cancer cell lines: a paradigm for cell line cross-contamination

1 reference

Cellosaurus release 49

14 July 2024

Proteomic analysis of ovarian cancer cells reveals dynamic processes of protein secretion and shedding of extra-cellular domains

1 reference

Cellosaurus release 49

14 July 2024

DNA fingerprinting of the NCI-60 cell line panel

1 reference

Cellosaurus release 49

14 July 2024

A genome-wide screen for microdeletions reveals disruption of polarity complex genes in diverse human cancers

1 reference

Cellosaurus release 49

14 July 2024

Therapeutic reactivation of mutant p53 protein by quinazoline derivatives

1 reference

Cellosaurus release 49

14 July 2024

Genomic complexity and AKT dependence in serous ovarian cancer

1 reference

Cellosaurus release 49

14 July 2024

JFCR39, a panel of 39 human cancer cell lines, and its application in the discovery and development of anticancer drugs

1 reference

Cellosaurus release 49

14 July 2024

Identification of cancer cell-line origins using fluorescence image-based phenomic screening

1 reference

Cellosaurus release 49

14 July 2024

The Cancer Cell Line Encyclopedia enables predictive modelling of anticancer drug sensitivity

1 reference

Cellosaurus release 49

14 July 2024

Essential gene profiles in breast, pancreatic, and ovarian cancer cells.

1 reference

Cellosaurus release 49

14 July 2024

Metabolite profiling identifies a key role for glycine in rapid cancer cell proliferation

1 reference

Cellosaurus release 49

14 July 2024

DNA profiling analysis of endometrial and ovarian cell lines reveals misidentification, redundancy and contamination

1 reference

Cellosaurus release 49

14 July 2024

Proteomic analysis of temporally stimulated ovarian cancer cells for biomarker discovery

1 reference

Cellosaurus release 49

14 July 2024

BRCA1/2 mutation analysis in 41 ovarian cell lines reveals only one functionally deleterious BRCA1 mutation

1 reference

Cellosaurus release 49

14 July 2024

Evaluating cell lines as tumour models by comparison of genomic profiles

1 reference

Cellosaurus release 49

14 July 2024

The exomes of the NCI-60 panel: a genomic resource for cancer biology and systems pharmacology

1 reference

Cellosaurus release 49

14 July 2024

Global proteome analysis of the NCI-60 cell line panel

1 reference

Cellosaurus release 49

14 July 2024

Type-specific cell line models for type-specific ovarian cancer research

1 reference

Cellosaurus release 49

14 July 2024

The metabolic demands of cancer cells are coupled to their size and protein synthesis rates

1 reference

Cellosaurus release 49

14 July 2024

In-depth proteomic analyses of ovarian cancer cell line exosomes reveals differential enrichment of functional categories compared to the NCI 60 proteome

1 reference

Cellosaurus release 49

14 July 2024

High resolution copy number variation data in the NCI-60 cancer cell lines from whole genome microarrays accessible through CellMiner

1 reference

Cellosaurus release 49

14 July 2024

Ovarian cancer cell line panel (OCCP): clinical importance of in vitro morphological subtypes

1 reference

Cellosaurus release 49

14 July 2024

A comprehensive transcriptional portrait of human cancer cell lines

1 reference

Cellosaurus release 49

14 July 2024

Parallel genome-scale loss of function screens in 216 cancer cell lines for the identification of context-specific genetic dependencies

1 reference

Cellosaurus release 49

14 July 2024

Metabolic signatures differentiate ovarian from colon cancer cell lines

1 reference

Cellosaurus release 49

14 July 2024

Identification of glycosylphosphatidylinositol-anchored proteins and ω-sites using TiO2-based affinity purification followed by hydrogen fluoride treatment

1 reference

Cellosaurus release 49

14 July 2024

Data for identification of GPI-anchored peptides and ω-sites in cancer cell lines

1 reference

Cellosaurus release 49

14 July 2024

Characterization of ovarian cancer cell lines as in vivo models for preclinical studies

1 reference

Cellosaurus release 49

14 July 2024

Long non-coding RNA expression profiling in the NCI60 cancer cell line panel using high-throughput RT-qPCR

1 reference

Cellosaurus release 49

14 July 2024

A landscape of pharmacogenomic interactions in cancer.

1 reference

Cellosaurus release 49

14 July 2024

Integrative proteomic profiling of ovarian cancer cell lines reveals precursor cell associated proteins and functional status

1 reference

Cellosaurus release 49

14 July 2024

A map of mobile DNA insertions in the NCI-60 human cancer cell panel.

1 reference

Cellosaurus release 49

14 July 2024

Simultaneous analyses of N-linked and O-linked glycans of ovarian cancer cells using solid-phase chemoenzymatic method

1 reference

Cellosaurus release 49

14 July 2024

Characterization of Human Cancer Cell Lines by Reverse-phase Protein Arrays

1 reference

Cellosaurus release 49

14 July 2024

Feasibility of drug screening with panels of human tumor cell lines using a microculture tetrazolium assay

1 reference

Cellosaurus release 49

14 July 2024

Experimental model systems of ovarian cancer: applications to the design and evaluation of new treatment approaches

1 reference

Cellosaurus release 49

14 July 2024

HLA class I and II genotype of the NCI-60 cell lines

1 reference

Cellosaurus release 49

14 July 2024

Signatures of mutation and selection in the cancer genome

1 reference

Cellosaurus release 49

14 July 2024

Redefining the relevance of established cancer cell lines to the study of mechanisms of clinical anti-cancer drug resistance

1 reference

Cellosaurus release 49

14 July 2024

Interrogation of Functional Cell-Surface Markers Identifies CD151 Dependency in High-Grade Serous Ovarian Cancer

1 reference

Cellosaurus release 49

14 July 2024

Integrated Genomic, Epigenomic, and Expression Analyses of Ovarian Cancer Cell Lines

1 reference

Cellosaurus release 49

14 July 2024

An Interactive Resource to Probe Genetic Diversity and Estimated Ancestry in Cancer Cell Lines

1 reference

Cellosaurus release 49

14 July 2024

Next-generation characterization of the Cancer Cell Line Encyclopedia

1 reference

Cellosaurus release 49

14 July 2024

Quantitative Proteomics of the Cancer Cell Line Encyclopedia.

1 reference

Cellosaurus release 49

14 July 2024

S100A1 expression in ovarian and endometrial endometrioid carcinomas is a prognostic indicator of relapse-free survival

1 reference

Cellosaurus release 49

14 July 2024

The role of estrogen in the survival of ovarian tumors--a study of the human ovarian adenocarcinoma cell lines OC-117-VGH and OVCAR3.

1 reference

Cellosaurus release 49

14 July 2024

Identification of ovarian high-grade serous carcinoma cell lines that show estrogen-sensitive growth as xenografts in immunocompromised mice

1 reference

Cellosaurus release 49

14 July 2024

p53 gene mutation analysis and antisense-mediated growth inhibition of human ovarian carcinoma cell lines

1 reference

Cellosaurus release 49

14 July 2024

Radiosensitivity profiles from a panel of ovarian cancer cell lines exhibiting genetic alterations in p53 and disparate DNA-dependent protein kinase activities

1 reference

Cellosaurus release 49

14 July 2024

High resistance to cisplatin in human ovarian cancer cell lines is associated with marked increase of glutathione synthesis

1 reference

Cellosaurus release 49

14 July 2024

Reversal of Adriamycin Resistance by Verapamil in Human Ovarian Cancer

1 reference

Cellosaurus release 49

14 July 2024

Mass homozygotes accumulation in the NCI-60 cancer cell lines as compared to HapMap Trios, and relation to fragile site location

1 reference

Cellosaurus release 49

14 July 2024

A resource for cell line authentication, annotation and quality control

1 reference

Cellosaurus release 49

14 July 2024

TCLP: an online cancer cell line catalogue integrating HLA type, predicted neo-epitopes, virus and gene expression

1 reference

Cellosaurus release 49

14 July 2024

Prioritization of cancer therapeutic targets using CRISPR-Cas9 screens

1 reference

Cellosaurus release 49

14 July 2024

established from medical condition

high grade ovarian serous adenocarcinoma

1 reference

Cellosaurus release 49

14 July 2024

derived from organism type

1 reference

Cellosaurus release 49

14 July 2024

http://purl.obolibrary.org/obo/BTO_0000812

1 reference

Cellosaurus release 49

14 July 2024

http://purl.obolibrary.org/obo/EFO_0003061

1 reference

Cellosaurus release 49

14 July 2024

http://purl.obolibrary.org/obo/CLO_0008171

1 reference

Cellosaurus release 49

14 July 2024

http://purl.obolibrary.org/obo/CLO_0008279

1 reference

Cellosaurus release 49

14 July 2024

http://purl.obolibrary.org/obo/CLO_0051451

1 reference

Cellosaurus release 49

14 July 2024

Identifiers

Cell Line Ontology ID

1 reference

Cellosaurus release 49

14 July 2024

1 reference

Cellosaurus release 49

14 July 2024

1 reference

Cellosaurus release 49

14 July 2024

1 reference

Cellosaurus release 49

14 July 2024

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q54937005&oldid=2258524755"